Methods
Accepted on 30 Oct 2025
StarTRAC-CYP2D6: a method for CYP2D6 allele-specific copy number determination using digital PCR
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
Type at least 3 characters
635 articles
Original Research
Published on 30 Oct 2025
Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1658616
- 778 views
Review
Published on 30 Oct 2025
Epigenetic pharmacology in aging: from mechanisms to therapies for age-related disorders
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1699296
- 456 views
Mini Review
Accepted on 28 Oct 2025
Inhibition of mesenchymal drift as a strategy for rejuvenation
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
Original Research
Accepted on 22 Oct 2025
"Pharmacogenetic Variations and Clinical Implications of Actionable CYP2D6/CYP2C19 Variants in Central Indian Patients with Common Mental Disorders"
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
- 365 views
Systematic Review
Accepted on 15 Oct 2025
Impact of CYP2C19 point-of-care testing on the clinical outcome in patients receiving personalized clopidogrel therapy: Systemic review and meta-analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
- 251 views
Original Research
Accepted on 09 Oct 2025
Effectiveness of Treatments to Prevent Femoral Periprosthetic Bone Loss in People Following Total Hip Arthroplasty: A Network Meta-analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
- 199 views
Original Research
Published on 09 Oct 2025
Patient and clinician perspectives on pharmacogenetic testing for antipsychotics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1689300
- 1,955 views
Original Research
Published on 08 Oct 2025
A digital twin of glimepiride for personalized and stratified diabetes treatment
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1686415
- 1,080 views
Original Research
Published on 02 Oct 2025
Genetic and serum biomarkers of NSAID hypersensitivity reactions
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1502755
- 1,834 views
Review
Published on 01 Oct 2025
Pharmacogenomics of antibiotic-induced hypersensitivity reactions: current evidence and implications in clinical practice
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1651909
- 2,197 views
Original Research
Published on 25 Sep 2025
Pharmacogenomic biomarkers of ACE inhibitor–induced cough in a multi-ethnic UAE cohort
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655617
- 1,755 views
Systematic Review
Published on 22 Sep 2025
Implementing pharmacogenetic testing in community pharmacy practice: a scoping review
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1659875
- 2,839 views
Review
Published on 19 Sep 2025
Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1651898
- 3,260 views
Original Research
Published on 19 Sep 2025
Prevalence of risk phenotypes associated with CYP2C9*2, *3, and VKORC1 c.-1639G>A genetic polymorphisms in world populations: implications in clinical practice
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1597379
- 1,442 views
- 1 citation
Original Research
Published on 18 Sep 2025
Higher prevalence of NUDT15 rs116855232 compared to TPMT rs1142345 in a Chinese cohort and its implications for thiopurine therapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1660719
- 1,460 views